Current Neuro-Oncology
Volume
26 Number 7
15 April 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 7, 15 April
Saito N, Hirai N, Sato S, Hayashi M, Iwabuchi S.
Delayed
Pseudoprogression in Glioblastoma Patients Treated With
Tumor-Treating Fields.
Cureus.
2024 Feb 28;16(2):e55147. doi:
10.7759/cureus.55147. PMID:
38558596. Case report. ˍ
*Pasqualetti F, Gabelloni M, Faggioni L, Aquaro GD, De Vietro F,
Mendola V, Spina N, Frey J, Montemurro N, Cantarella M, Caccese M,
Gadducci G, Giannini N, Valenti S, Morganti R, Ius T, Caffo M,
Vergaro G, Cosottini M, Naccarato AG, Lombardi G, Bocci G, Neri E,
Paiar F.
Glioblastoma and Internal
Carotid Artery Calcium Score: A Possible Novel Prognostic
Partnership?
J
Clin Med. 2024 Mar 6;13(5):1512. doi:
10.3390/jcm13051512. PMID:
38592330. Observational study. ˍ
*Kozel G, Gurses ME, Gecici NN, Gökalp E, Bahadir S, Merenzon
MA, Shah AH, Komotar RJ, Ivan ME.
Chat-GPT
on brain tumors: An examination of Artificial Intelligence/Machine
Learning's ability to provide diagnoses and treatment plans for
example neuro-oncology cases.
Clin
Neurol Neurosurg. 2024 Mar 9;239:108238. doi:
10.1016/j.clineuro.2024.108238. PMID:
38507989. Observational study˰
ˍ
Barry N, Koh ES, Ebert MA, Moore A, Francis RJ, Rowshanfarzad P,
Hassan GM, Ng SP, Back M, Chua B, Pinkham MB, Pullar A, Phillips
C, Sia J, Gorayski P, Le H, Gill S, Croker J, Bucknell N,
Bettington C, Syed F, Jung K, Chang J, Bece A, Clark C, Wada M,
Cook O, Whitehead A, Rossi A, Grose A, Scott
AM.
[18]F-fluoroethyl-l-tyrosine
positron emission tomography for radiotherapy target delineation:
Results from a Radiation Oncology credentialing program.
Phys
Imaging Radiat Oncol. 2024 Mar 13;30:100568. doi:
10.1016/j.phro.2024.100568. PMID:
38585372. Observational study. ˍ
Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L,
Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus
MV.
Intraventricular CARv3-TEAM-E T
Cells in Recurrent Glioblastoma.
N
Engl J Med. 2024 Mar 13;390(14):1290-1298. doi:
10.1056/NEJMoa2314390. PMID:
38477966. Interventional study. ˍ
Hansen ST, Jacobsen KS, Kofoed MS, Petersen JK, Boldt HB, Dahlrot
RH, Schulz MK, Poulsen FR.
Prognostic
factors to predict postoperative survival in patients with
recurrent glioblastoma.
World
Neurosurg X. 2024 Mar 13;23:100308. doi:
10.1016/j.wnsx.2024.100308. PMID:
38584878. Observational study. ˍ
Lulla RR, Buxton A, Krailo MD, Lazow MA, Boue DR, Leach JL, Lin T,
Geller JI, Kumar SS, Nikiforova MN, Chandran U, Jogal SS, Nelson
MD Jr, Onar-Thomas A, Haas-Kogan DA, Cohen KJ, Kieran MW, Gajjar
A, Drissi R, Pollack IF, Fouladi M.
Vorinostat,
temozolomide or bevacizumab with irradiation and maintenance
BEV/TMZ in pediatric high-grade glioma: A Children's Oncology
Group Study.
Neurooncol
Adv. 2024 Mar 14;6(1):vdae035. doi:
10.1093/noajnl/vdae035. PMID:
38596718. Interventional study. ˍ
Wu Y, Han J, Li R, Chen J, Mao S, Zeng L.
Effect
of memory therapy on enhancing postoperative cognitive function
recovery and alleviating mood disturbances in brain glioma
patients.
Am
J Transl Res. 2024 Mar 15;16(3):998-1008. doi:
10.62347/UUTB6644. PMID:
38586107. Observational study. ˍ
*Wang J, Du Q, Chen J, Liu J, Gu Z, Wang X, Zhang A, Gao S, Shao
A, Zhang J, Wang Y.
Tumor treating
fields in glioblastoma: long-term treatment and high compliance as
favorable prognostic factors.
Front
Oncol. 2024 Mar 20;14:1345190. doi:
10.3389/fonc.2024.1345190. PMID:
38571508. Observational study. ˍ
*Fernández-Valverde F, Bautista-Bárcena MP,
Roldán-Romero E, Solivera-Vela J, Bravo-Rodríguez F,
Ramos-Gómez MJ.
Prognostic value
of brain perfusion by MRI in the initial study of high grade
gliomas.
Radiologia
(Engl Ed). 2024 Mar 22;66(2):114-120. doi:
10.1016/j.rxeng.2022.12.010. PMID:
38614528. Observational study˰
ˍ
Mak LS, Li X, Chan WYK, Leung AWK, Cheuk DKL, Yuen LYP, So JCC, Ha
SY, Liu APY.
Case report:
Therapy-related myeloid neoplasms in three pediatric cases with
medulloblastoma.
Front
Oncol. 2024 Mar 26;14:1364199. doi:
10.3389/fonc.2024.1364199. PMID:
38595820. Case report. ˍ
Phillips MCL, Thotathil Z, Dass PH, Ziad F, Moon BG.
Ketogenic
metabolic therapy in conjunction with standard treatment for
glioblastoma: A case report.
Oncol
Lett. 2024 Mar 26;27(5):230. doi:
10.3892/ol.2024.14363. PMID:
38586213. Case report. ˍ
*Duffau H.
Case report: when art is
faced with brain surgery: acute change in creative style in a
painter after glioma resection.
Front
Oncol. 2024 Mar 28;14:1394609. doi:
10.3389/fonc.2024.1394609. PMID:
38606096. Case report. ˍ
*Qin Z, Yang B, Jin X, Zhao H, Liu N.
Cuproptosis
in glioblastoma: unveiling a novel prognostic model and
therapeutic potential.
Front
Oncol. 2024 Mar 28;14:1359778. doi:
10.3389/fonc.2024.1359778. PMID:
38606090. Laboratory investigation. ˍ
Barnett AE, Ozair A, Bamashmos AS, Li H, Bosler DS, Yeaney G, Ali
A, Peereboom DM, Lathia JD, Ahluwalia MS.
MGMT
Methylation and Differential Survival Impact by Sex in
Glioblastoma.
Cancers
(Basel). 2024 Mar 31;16(7):1374. doi:
10.3390/cancers16071374. PMID:
38611052. Observational study. ˍ
Bieth T, Facque V, Altmayer V, Poisson I, Ovando-Tellez M,
Moreno-Rodriguez S, Lopez-Persem A, Mandonnet E, Volle E.
Impaired
creative cognition after surgery for an IDH-mutated glioma: A
proof-of-concept study.
Cortex.
2024 Mar 31;174:219-233. doi:
10.1016/j.cortex.2024.02.017. PMID:
38593576.. Observational study. ˍ
Fehrenbach MK, Wilhelmy F, Wende T, Güresir E, Kasper
J.
Perioperative psychological distress
in patients with intracranial tumors; a single center study.
J
Neurooncol. 2024 Apr 2. doi:
10.1007/s11060-024-04657-8. PMID:
38563854. Observational study˰
ˍ
Xiang Y, Chen Y, Xu Z, Zhou S, Qin Z, Chen L, Xiao D, Liu
S.
Real-world cost-effectiveness
analysis: Tumor Treating Fields for newly diagnosed glioblastoma
in China.
J
Neurooncol. 2024 Apr 2. doi:
10.1007/s11060-024-04662-x. PMID:
38563851. Observational study˰
ˍ
Mirzayeva L, Uçar M, Kaymaz AM, Temel E.
Intraoperative
magnetic resonance imaging in glioma surgery: a single-center
experience.
J
Neurooncol. 2024 Apr 3. doi:
10.1007/s11060-024-04660-z. PMID:
38568377. Observational study. ˍ
Ricklefs FL, Wollmann K, Salviano-Silva A, Drexler R, Maire CL,
Kaul MG, Reimer R, Schüller U, Heinemann S, Kolbe K, Mummert
T, Glatzel M, Peine S, Gempt J, Westphal M, Dührsen L,
Lamszus K.
Circulating extracellular
vesicles as biomarker for diagnosis, prognosis and monitoring in
glioblastoma patients.
Neuro
Oncol. 2024 Apr 3:noae068. doi:
10.1093/neuonc/noae068. PMID:
38567448. Observational study˰
ˍ
Spoor JKH, Donders-Kamphuis M, Veenstra WS, van Dijk SA, Dirven
CMF, Sillevis Smitt PAE, van den Bent MJ, Leenstra S, Satoer
DD.
Cognition and health-related
quality of life in long-term survivors of high-grade glioma: an
interactive perspective from patient and caregiver.
Acta
Neurochir (Wien). 2024 Apr 3;166(1):166. doi:
10.1007/s00701-024-06037-7. PMID:
38565800. Observational study. ˍ
Obrecht-Sturm D, Schömig L, Mynarek M, Bison B, Schwarz R,
Pietsch T, Pfister SM, Sill M, Sturm D, Sahm F, Kortmann RD,
Gerber NU, von Bueren AO, Fleischhack G, Schüller U,
Nussbaumer G, Benesch M, Rutkowski S.
Treatment
response as surrogate to predict risk for disease progression in
pediatric medulloblastoma with persistent MRI lesions after
first-line treatment.
Neuro
Oncol. 2024 Apr 5:noae071. doi:
10.1093/neuonc/noae071. PMID:
38578306. Observational study˰
ˍ
Zugman M, Haslam A, Prasad V.
INDIGO:
Example of inappropriate crossover and why PFS cannot be the
primary outcome in gliomas.
J
Cancer Policy. 2024 Apr 6;40:100476. doi:
10.1016/j.jcpo.2024.100476. PMID:
38588795. Comment˰ ˍ
Related article:
Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters
KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F,
Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y,
Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la
Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L,
Hassan I, Wen PY, Cloughesy TF.
Vorasidenib
in IDH1- or IDH2-Mutant Low-Grade Glioma.
N
Engl J Med.
2023 Jun 4. doi:
10.1056/NEJMoa2304194. PMID:
37272516. Interventional study. ˍ
*Geurts M, Preusser M.
Locoregional
delivery of CAR-T cells - breaking the spell in
glioblastoma?
Neuro
Oncol. 2024 Apr 9:noae063. doi:
10.1093/neuonc/noae063. PMID:
38592708. Editorial. ˍ
Relater articles:
-Choi BD, Gerstner ER, Frigault
MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT,
Gallagher K, Maus MV.
Intraventricular
CARv3-TEAM-E T Cells in Recurrent Glioblastoma.
N
Engl J Med.
2024 Mar 13;390(14):1290-1298. doi:
10.1056/NEJMoa2314390. PMID:
38477966. Interventional study. ˍ
-Bagley SJ, Logun M, Fraietta
JA, Wang X, Desai AS, Bagley LJ, Nabavizadeh A, Jarocha D, Martins
R, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz R, Jadlowsky
JK, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen
F, Sun Y, Gladney W, Barrett D, Nasrallah MP, Hwang WT, Ming GL,
Song H, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke
DM.
Intrathecal
bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent
glioblastoma: phase 1 trial interim results.
Nat
Med. 2024
Mar 13. doi:
10.1038/s41591-024-02893-z. PMID:
38480922. Interventional study˰ ˍ
-Brown CE, Hibbard JC, Alizadeh
D, Blanchard MS, Natri HM, Wang D, Ostberg JR, Aguilar B, Wagner
JR, Paul JA, Starr R, Wong RA, Chen W, Shulkin N, Aftabizadeh M,
Filippov A, Chaudhry A, Ressler JA, Kilpatrick J, Myers-McNamara
P, Chen M, Wang LD, Rockne RC, Georges J, Portnow J, Barish ME,
D'Apuzzo M, Banovich NE, Forman SJ, Badie B.
Locoregional
delivery of IL-13Rα2-targeting CAR-T cells in recurrent
high-grade glioma: a phase 1 trial.
Nat
Med. 2024
Mar 7. doi:
10.1038/s41591-024-02875-1. PMID:
38454126. Interventional study. ˍ
Tohidinezhad F, Zegers CML, Vaassen F, Dijkstra J, Anten M, Van
Elmpt W, De Ruysscher D, Dekker A, Eekers DBP, Traverso
A.
Predicting the risk of
neurocognitive decline after brain irradiation in adult patients
with a primary brain tumor.
Neuro
Oncol. 2024 Apr 10:noae035. doi:
10.1093/neuonc/noae035. PMID:
38595122. Observational study. ˍ
Gong J, Mita AC, Wei Z, Cheng HH, Mitchell EP, Wright JJ, Ivy SP,
Wang V, Gray RC, McShane LM, Rubinstein LV, Patton DR, Williams
PM, Hamilton SR, Tricoli JV, Conley BA, Arteaga CL, Harris LN,
O'Dwyer PJ, Chen AP, Flaherty KT.
Phase
II Study of Erdafitinib in Patients With Tumors With Fibroblast
Growth Factor Receptor Mutations or Fusions: Results From the
NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.
JCO
Precis Oncol. 2024 Apr 11;8:e2300407. doi:
10.1200/PO.23.00407. PMID:
38603650. Interventional study˰
ˍ
Lunde CE, Dudek MR, Talbert CA, Sieberg CB, Silva KE, Papadelis C,
Ullrich NJ, Manley PE, Moulton EA.
The
long-term impact of cerebellar tumor resection on executive
functioning, anxiety, and fear of pain: A mixed methodology pilot
study.
Appl
Neuropsychol Child. 2024 Apr 11:1-11. doi:
10.1080/21622965.2024.2337208. PMID:
38604218. Observational study˰
ˍ
Cicutti SE, Del Río RJ, Cáceres A, Gonzalez Ramos
JD.
Pediatric hemispheric cerebellar
low-grade gliomas: clinical approach, diagnosis, and management
challenges-experience at a tertiary care children's
hospital.
Childs
Nerv Syst. 2024 Apr 12. doi:
10.1007/s00381-024-06394-9. PMID:
38607550. Observational study˰
ˍ
Bocanegra-Becerra JE, Novoa-Ramírez LF, Latorre-Zúñiga
AJ, Tacas-Gil N, Rojas-Apaza R.
Primary
intracranial peripheral primitive neuroectodermal tumor: lessons
from an exceptionally rare neoplasm. Illustrative case.
J
Neurosurg Case Lessons. 2024 Apr 15;7(16):CASE24133.
doi:
10.3171/CASE24133. PMID:
38621307. Case report. ˍ
*Ezaki T, Tanaka T, Tamura R, Ohara K, Yamamoto Y, Takei J,
Morimoto Y, Imai R, Kuranai Y, Akasaki Y, Toda M, Murayama Y,
Miyake K, Sasaki H.
Status of
alternative angiogenic pathways in glioblastoma resected under and
after bevacizumab treatment.
Brain
Tumor Pathol. 2024 Apr 15. doi:
10.1007/s10014-024-00481-0. PMID:
38619734. Observational study; Laboratory investigation. ˍ
*Shelton WJ, Mathews AP, Aljiboori K, Nix JS, Gokden M, Rodriguez
A.
A rare case of atypical intradural
extramedullary glioblastoma diagnosed utilizing next-generation
sequencing and methylation profiling: illustrative case.
J
Neurosurg Case Lessons. 2024 Apr 15;7(16):CASE24103.
doi:
10.3171/CASE24103. PMID:
38621302. Case report. ˍ